Código QR (código de barras bidimensional)

Dapagliflozin & pioglitazone combination therapy in T2DM with or without MASLD - a systematic review and meta-analysis: PRO-2 study

AimsTo evaluate the efficacy and safety of dapagliflozin plus pioglitazone versus comparators on metabolic control and hepatic steatosis in adults with type 2 diabetes mellitus (T2DM), with or without metabolic dysfunction-associated steatotic liver disease (MASLD).MethodsWe conducted a systematic r...

ver descrição completa

Na minha lista:
Principais autores: Shashank Joshi, Shambo Samrat Samajdar, Arvind Gupta, Mithun Bhartia, Sailesh Lodha, Supratik Bhattacharyya, Krishna Seshadri, Lakshmi Nagendra, A. G. Unnikrishnan, Dakshata Padhye, Lakshmi Nalini Kopalle, Ashok Kumar Das, Om Lakhani, Jothydev Kesavadev, Ameya Joshi, Sambit Das, Smriti Gadia, Thamburaj Anthuvan
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2026-07-01
coleção:Frontiers in Clinical Diabetes and Healthcare
Assuntos:
combination therapy
dapagliflozin
MASLD
NAFLD
pioglitazone
SRMA
Acesso em linha:https://www.frontiersin.org/articles/10.3389/fcdhc.2026.1733995/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados